Rash and edema shortly after initial exposure to low dose cenobamate
Cenobamate (CNB) is an antiseizure medication (ASM) approved for the treatment of focal epilepsy. Rash and edema are uncommon adverse effects of this medication. We report two patients with medically refractory epilepsy (MRE) who received CNB and developed chest and facial rash and edema after the i...
Saved in:
Main Authors: | Christopher Saouda, Yamane Makke, Helen Edelberg, Mohamad Z. Koubeissi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-09-01
|
Series: | Epilepsy & Behavior Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589986425000607 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergistic seizure reduction in patient with persistently elevated N-desmethylclobazam levels, CYP450 genetic polymorphism, and responsive neurostimulator targeting centromedian nuclei of bilateral thalami
by: Andrew Zillgitt, et al.
Published: (2025-09-01) -
Severe lichenified skin rash associated with apalutamide administration
by: Chisato Watanabe, et al.
Published: (2025-07-01) -
Flagellate Rash in Chikungunya: A Comprehensive Review of Dermatological Manifestations
by: Nikhil Mehta, et al.
Published: (2025-07-01) -
Skin rash along with pulmonary involvement: A case report
by: Pradipta Bhattacharjee
Published: (2025-01-01) -
Acneiform rash — skin toxic reaction to the use of EGFR inhibitors
by: E. A. Shatokhina, et al.
Published: (2019-01-01)